...
首页> 外文期刊>International Journal of Chronic Obstructive Pulmonary Disease >Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary diseases in the People’s Republic of China
【24h】

Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary diseases in the People’s Republic of China

机译:中华人民共和国慢性肺部疾病患者空肠肺孢菌的定殖调查

获取原文
           

摘要

Background: The detection of Pneumocystis jirovecii DNA in respiratory specimen from individuals who do not have signs or symptoms of pneumonia has been defined as colonization. The role of P. jirovecii colonization in the development or progression of various lung diseases has been reported, but little information about P. jirovecii colonization in patients is available in the People’s Republic of China.Objective: To determine the prevalence of P. jirovecii colonization in patients with various pulmonary diseases, including the acute and stable stage of COPD, interstitial lung diseases, cystic fibrosis, and chronic bronchiectasis.Materials and methods: A loop-mediated isothermal amplification (LAMP) and a conventional polymerase chain reaction (PCR) method for detecting P. jirovecii were developed. Ninety-eight HIV-negative patients who were followed-up and who had undergone bronchoscopy for diagnosis of various underlying respiratory diseases were included in the study. Sputa of these patients were analyzed with LAMP amplification of P. jirovecii gene. In addition, conventional PCR, Giemsa and Gomori’s methenamine silver nitrate staining assays were applied to all specimens.Results: The sensitivity and specificity test showed that there was no cross-reaction with other fungi or bacteria in detecting the specific gene of P. jirovecii by LAMP, and the minimum detection limits by LAMP was 50 copies/mL. P. jirovecii DNA was detected in 62 of 98 (63.3%) sputa specimens by LAMP assay and 22.45% (22/98) by conventional PCR. However, no P.?jirovecii cysts were found by Giemsa and Gomori’s methenamine silver nitrate in all of gene-positive specimens.Conclusion: The results of our study showed that prevalence of P. jirovecii colonization is particularly high in patients with chronic pulmonary diseases in People’s Republic of China, and the LAMP method is better for evaluation of the colonization of P. jirovecii in sputum specimen than conventional PCR.
机译:背景:在没有肺炎体征或症状的个体的呼吸道标本中检测到的吉氏肺孢子虫DNA被定为定植。已有报道吉氏疟原虫定植在各种肺部疾病的发生或发展中的作用,但关于患者中吉氏疟原虫定植的信息很少。适用于患有多种肺部疾病的患者,包括COPD的急性和稳定期,间质性肺部疾病,囊性纤维化和慢性支气管扩张。材料和方法:环介导的等温扩增(LAMP)和常规聚合酶链反应(PCR)方法开发了用于检测波罗氏疟原虫的方法。这项研究包括了98例HIV阴性患者,这些患者经过随访并接受了支气管镜检查以诊断各种潜在的呼吸系统疾病。用LAMP扩增jirovecii基因分析这些患者的痰液。此外,常规PCR,Giemsa和Gomori's的甲基苯二甲胺硝酸银染色法均适用于所有标本。结果:敏感性和特异性测试表明,在通过酶切法检测罗氏疟原虫的特定基因时,没有与其他真菌或细菌发生交叉反应。 LAMP,LAMP的最低检测限为50拷贝/ mL。通过LAMP分析在98个痰标本中有62个(63.3%)和常规PCR在22.45%(22/98)中检出了吉氏疟原虫DNA。然而,在所有基因阳性标本中,Giemsa和Gomori的二甲亚胺硝酸银均未发现杆状毕赤氏酵母囊肿。中华民国,并且LAMP方法比常规PCR更好地用于评估痰标本中的罗氏疟原虫定植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号